| Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray (NCT05437029) | Kenneth Palmer | 2022-06-15 |
| A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults (NCT05091307) | Janssen Vaccines & Prevention B.V. | 2021-11-02 |
| A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) (NCT04765384) | Janssen Vaccines & Prevention B.V. | 2021-08-27 |
| A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults (NCT04908722) | Janssen Vaccines & Prevention B.V. | 2021-06-18 |
| Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 (NCT04858633) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-03-22 |
| Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light (NCT04741061) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-02-19 |
| An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine (NCT04713488) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-01-15 |
| Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection (NCT04640233) | Dr. Reddy's Laboratories Limited | 2020-11-30 |
| A Study of Ad26.COV2.S in Adults (COVID-19) (NCT04436276) | Janssen Vaccines & Prevention B.V. | 2020-07-15 |